Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Griesinger:2022:10.1016/j.annonc.2022.10.410,
author = {Griesinger, F and Popat, S and Okhuoya, P and Servidio, L and Fonseca, MJ and Tolani, E and Lu, S and Zacharias, S},
doi = {10.1016/j.annonc.2022.10.410},
pages = {S1587--S1587},
publisher = {ELSEVIER},
title = {Global real-world (rw) study of patients (pts) with epidermal growth factor receptor (EGFR) mutated advanced non-small cell lung cancer (NSCLC) treated with first-line (1L) osimertinib: Interim analysis of an rw pt registry in Germany},
url = {http://dx.doi.org/10.1016/j.annonc.2022.10.410},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Griesinger,F
AU - Popat,S
AU - Okhuoya,P
AU - Servidio,L
AU - Fonseca,MJ
AU - Tolani,E
AU - Lu,S
AU - Zacharias,S
DO - 10.1016/j.annonc.2022.10.410
EP - 1587
PB - ELSEVIER
PY - 2022///
SN - 0923-7534
SP - 1587
TI - Global real-world (rw) study of patients (pts) with epidermal growth factor receptor (EGFR) mutated advanced non-small cell lung cancer (NSCLC) treated with first-line (1L) osimertinib: Interim analysis of an rw pt registry in Germany
UR - http://dx.doi.org/10.1016/j.annonc.2022.10.410
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000897943700377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -